CLINICAL_TRIALS
trial_result
· 2011-01-11
Clinical Trial Update: Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin [Phase 3]
Summary
Phase 3 trial evaluating insulin glulisine added to basal insulin glargine in adults with type 2 diabetes; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED